COVID-19: US Company, Novavax, to Commence Human Trials of ‘Recombinant Vaccine’

An American biotechnology company, Novavax, is set to commence human trials of COVID-19 vaccine in Australia. Announcing this Tuesday, the firm said it was hopeful the vaccine could be available…

Read More